Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8
Primary Industries
- Medical
- Device
- Surgical
- Electrical & Electronics
- Semiconductors
- Computers & Office Equipment
- RAM
- Supply
- Diagnostic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 2991
License Grant
Trial in the Company's U.S. case based on the Kastenhofer patent in Federal District Court in California concluded in October 2007 with a jury finding that the patent was invalid. The licensee was found to infringed a patent covering features of the chemically treated and multi-layered guide wire tubes that enable catheters to slide into place. The jury also found for patent owner on its counterclaim that sale by the Company of its balloon catheters and stent delivery systems infringe owner's Fontirroche patent. The Court has denied the Company's post trial motions.
License Property
Fontirroche patents pertain to designs for balloon catheters and stent delivery systems.
IPSCIO Record ID: 1197
License Grant
A large semiconductor company was successful in a lawsuit against another company for infringement of its SDR SDRAM and DDR SDRAM related patents.
Specifically, the jury found that each of the ten selected patent claims was supported by the written description, and was not anticipated or rendered obvious by prior art; therefore, none of the patent claims were invalid. The jury also found that licensee infringed all eight of the patent claims for which the jury was asked to determine infringement; the court had previously determined on summary judgment that licensee infringed the other two claims at issue in the trial.
IPSCIO Record ID: 28463
License Grant
A U.S. District Court jury in Arizona found that certain of W.L. Gore Associates Inc. ePTFE vascular grafts and stent-grafts infringe the company's patent number 6,436,135. The jury also found that Gore willfully infringed the patent. In a second phase of the trial, the court ruled that Gore failed to prove that the patent is unenforceable due to inequitable conduct.
IPSCIO Record ID: 29584
License Grant
The District Court entered final judgment in the case. Licensor, claims that we infringed certain U.S. patents related to an electronic surface mount package, and is seeking injunctive relief and damages.
License Property
The jury returned a verdict ruling in favor of Licensor and found that Licensee willfully infringed on three different patents, specifically U.S. Patent Nos. 5,656,985; 6,297,720; and 6,344,785.
In addition, although the District Court granted Licensor's motion for a permanent injunction against the eight product groups subject to the jury verdict, the District Court granted Licensee's emergency motion to stay the injunction for 90 days through October 15, 2013.
Field of Use
The rights granted apply to the electronics industry.
IPSCIO Record ID: 26864
License Grant
University is willing to grant a worldwide, exclusive license in the defined FIELD OF USE to Licensee. The University is the owner and that it has the right to exclusively license those inventions which are the subject matter of USC File No. 2651 entitled 'Balloon Protection Guide Wire Device For Carotid Balloon Angioplasty and Stenting' and USC Pile 2639 entitled 'New Balloon-Inflated Carotid Artery Stent to Assist in Carotid Artery Balloon Angioplasty'.
License Property
Guardian Embolization Protection System patented technology with primary use in the neurointerventional and cardiology markets these markets focus on arteries and veins leading to the brain and those in the heart, and the removal of blockages in these veins and arteries. The device is designed to prevent deadly embolisms during surgery to clear blocked arteries and prevent strokes and heart attacks. The key to this device, known as the Guardian System, is a thin string of wire, really a metal tube not much larger in diameter than a human hair, with a marble-sized balloon attached toward the end.
USC File 2651 U.S. Patent Application Serial No. 08/767,221 filed December 16, 1996 (abandoned) entitled 'Cerebral Protection Balloon For Use In Carotid Artery Angioplasty and Stenting'
USC File 2561 U.S. Patent Application Serial No. 08/906,890 filed August 6,1997 (which is a continuation of U.S. Ser. No. 08/767,221), entitled Angioplasty Catheter'.
USC File 2561 PCT Patent Application Serial No. PCT/US97/23257 filed December16, 1997 and corresponding to U.S. Patent Applications Serial Nos. 08/767,221and 08/906,890.
USC File 2639 Invention Disclosure entitled 'New Balloon-Inflated Carotid Artery Stent to Assist in Carotid Artery Balloon Angioplasty'.
Field of Use
'FIELD OF USE' shall mean diagnostic and/or therapeutic devices to be used in the treatment or management of patients via the carotid artery or other arteries or veins.
IPSCIO Record ID: 3938
License Grant
U.S. Corp. announced that a federal U.S. district court jury in San Francisco awarded it past damages and on-going royalties, finding that another U.S. corporation's manufacture, sale and use of its Amplatzer®Occluder and vascular plug product lines infringed claims of two U.S. patents owned by licensor.
License Property
The patents involved in this case are U.S. Patent No's. 6,306,141 and 5,067,957, known as the Jervis patents. The 141 patent covers self-expanding medical devices using stress to restrain a metal alloy that will expand to its original shape upon being released from a restraint, such as a sheath. For example, this invention allows doctors to locate and expand a medical device to repair holes in the heart, treat aortic aneurysms, place stents within the peripheral vasculature or treat damaged or diseased heart valves via a less invasive, transcatheter heart valve procedure. The 957 patent, which expired in 2004, covers a method of treatment using shape memory alloys, such as nitinol, in accordance with the Jervis inventions.
Field of Use
The rights granted apply to the medical industry.
IPSCIO Record ID: 26835
License Grant
University hereby grants the Worldwide right under the Patent Rights to develop, manufacture, have manufactured, use, sell and offer for sale the Licensed Products.
License Property
U.S. University licensed its rights to U.S. Patent Application 09/442,666 filed 1/18/99 and based on USA Provisional filing #60/108,968 filed 11/18/98 entitled 'Expandable MRI Receiving Coil' and Continuation of U.S. Patent Application #09/517,894 filed 3/23/00 entitled ' Catheter Antenna for Magnetic Resonance Imaging' to its U.S.-based collaborative research partner.and offer for sale the products.
Field of Use
'Territory' shall mean worldwide.
IPSCIO Record ID: 714
License Grant
Licensor, an individual, hereby grants to Licensee a world-wide exclusive, nontransferable, personal, sublicenseable only to those companies against which Licensee enforces the Rentrop Patents pursuant to this Agreement, revocable, royalty-bearing license under the Rentrop Patents to make, use, offer for sale, import, sell, or otherwise dispose of Licensed Catheters.
Licensor hereby grants to the Licensee a world-wide exclusive, nontransferable, personal, subLicenseable, as a result of the litigation in the U.S. District Court for the Southern District of New York. The Litigation was tried to the jury, resulting in a jury verdict on December 8, 2006 of infringement of claims 1, 8, and 15-17 of U.S. Patent Nos. 6,673,064. The License granted under this Agreement shall continue in full force and effect from the effective date until January 4, 2020.
License Property
Licensor is the sole inventor of and owns all right, title, and interest in and to U.S. Patent Nos. 6,440,125 and 6,673,064 and any applications claiming priority thereto.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
